Medical Cannabis in Poland: Record Data from the Ministry of Health

In 2023, Poland saw a significant rise in medical cannabis interest, with a record purchase of 4,658 kilograms, highlighting a shift in societal attitudes and increased trust in its medical applications. The growth in medical cannabis use signals a need for more research and opens new therapeutic possibilities and its potential role in future medical treatments and patient care.

In 2023, Poles demonstrated a clear increase in their interest in medical cannabis, reaching new records. Rafał Mundry, using data from the Ministry of Health, revealed that last year in Poland, an impressive 4,658 kilograms of this pharmaceutical raw material were purchased. This figure not only draws attention but also prompts reflection on the changing societal attitude towards medical cannabis.

For more news like this, along with all the latest in legalization, research, and lifestyle, download our free cannabis news app.

Historical Medical Cannabis Trends

Let’s analyze historical medical cannabis data to better understand this trend. Since 2019, we’ve observed a dynamic increase—from 33 kilograms in the first year, through 94 kilograms in 2020, to over 4,600 kilograms in 2023. The number of fulfilled prescriptions also significantly grew, reaching nearly 277,000 last year. This indicates growing trust in the medical applications of cannabis and easier access for patients.

How Is Such Data Collected?

The Ministry of Health, together with the e-Health Center, introduced a new analytical model that allows for more precise calculations. This is important because the quality and accuracy of data are crucial for understanding medical cannabis trends and societal needs. However, it’s worth remembering the challenges, such as the variance in data quality provided by pharmacies, which can affect the overall interpretation of results.

Collecting data on medical cannabis comes with certain challenges, including differences in the quality of data provided by individual pharmacies. Not all information is verified by the National Health Fund, which can affect the overall analysis and interpretation of available data.

Conclusions and Perspectives for the Future of Medical Cannabis

The increased interest in medical cannabis in Poland in 2023 is not only a symptom of a changing societal attitude but also a signal for future research and market development. With the growing popularity of this raw material, it becomes important to conduct further studies that can contribute to a better understanding of its properties and potential applications.

The record purchases of medical cannabis in Poland in 2023 are an important signal for patients, doctors, and policymakers. The market development and increased interest in this pharmaceutical raw material open up new therapeutic possibilities, prompting reflection on the future of medicine and its development directions. As society becomes more open to alternative forms of treatment, medical cannabis can play a key role in improving the quality of life for many patients.

—

(Featured image by Jeff W via Unsplash)

DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Fakty Konopne, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.